August 9, 2020

The Niche

Knoepfler lab stem cell blog

stem cell cosmetics

3 min read

Remember our old friends Liveyon? Their leader John Kosolcharoen? Liveyon’s continuing metamorphosis This biologics supply firm has gone through several stages of corporate metamorphosis as a supplier of biologics including at first a purported living umbilical cord stem cell product. That stem cell thrust ultimately landed a dozen or more people in the hospital as some of the product was somehow contaminated with bacteria along the way before injection in patients. There was a recall, an FDA warning letter, lawsuits, and a voluntary suspension …Read More

2 min read

Stem cell studies continue to make big news with a mixed bag of trends, and some good stem cell news and others not so much. Mesoblast ($MESO) had its stock suspended for quite so time recently in anticipation of a big announcement. When that news came today it was discouraging in the form of its partner Teva choosing to end their relationship with Mesoblast on a stem cell heart disease trial. Mesoblast spun this as something good that they regained the rights from Teva, but investors …Read More

1 min read

What is stem cell snake oil? Stem cells are exotic things ensconced away in biomedical research labs, right? Well, maybe not entirely so these days. It turns out that you can try to sell products for a lot of money by slapping “stem cells” on the label including cosmetics. Take Nordstrom’s. It has 80 stem cell products available online. These cosmetic products range in price up to $850 for the priciest one, ‘Bee Venom & Placenta’ 24 Carat Gold Ultimate Crème from Rodial. These kinds of …Read More

3 min read

IntelliCell BioSciences, Inc. of New York, a clinical stem cell establishment, has had a rough time of it lately. For example, a recent piece of bad news is that there is an impending foreclosure sale of the company’s assets. What exactly that means for the company more broadly remains unknown, but a few people tell me (take this with a grain of salt either way) that the company is still seeing patients. IntelliCell also has run into issues on multiple occasions including in 2012 with the FDA …Read More